NCT03909126View on ClinicalTrials.gov

Pertussis Vaccination in Pregnant Women

PHASE4CompletedINTERVENTIONAL
Enrollment

946

Participants

Timeline

Start Date

June 1, 2019

Primary Completion Date

May 30, 2021

Study Completion Date

May 30, 2021

Conditions
Pertussis
Interventions
BIOLOGICAL

Boostrix administered during gestational diabetes screening

Boostrix administered during gestational diabetes screening

BIOLOGICAL

Boostrix administered in high volume obstetric clinic

Boostrix administered in high volume obstetric clinic

Trial Locations (3)

Unknown

CLSC Montérégie, Longueuil

CLSC Capitale Nationale, Québec

H3T 1C5

CHU Sainte-Justine, Montreal

All Listed Sponsors
collaborator

Ministere de la Sante et des Services Sociaux

OTHER

lead

St. Justine's Hospital

OTHER

NCT03909126 - Pertussis Vaccination in Pregnant Women | Biotech Hunter | Biotech Hunter